2,139,057 Shares in Ventas, Inc. $VTR Purchased by Hsbc Holdings PLC

Key Points

• HSBC Holdings PLC purchased 2.14 million Ventas shares in the second quarter, worth approximately $190.1 million and representing about 0.42% of the healthcare REIT.
• Institutional investors and hedge funds collectively own 94.18% of Ventas, while several other investment firms recently initiated positions.
• Analysts maintain a favorable outlook, with a consensus rating of “Moderate Buy” and an average price target of $98. Ventas also beat quarterly earnings and revenue estimates, reporting $0.97 EPS and $1.73 billion in revenue.

Hsbc Holdings PLC bought a new stake in Ventas, Inc. (NYSE:VTR - Free Report) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 2,139,057 shares of the real estate investment trust's stock, valued at approximately $190,099,000. Hsbc Holdings PLC owned approximately 0.42% of Ventas as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the stock. Dynamic Wealth Strategies LLC bought a new stake in Ventas in the first quarter worth about $25,000. Silvant Capital Management LLC bought a new stake in shares of Ventas in the 2nd quarter worth approximately $28,000. Meeder Asset Management Inc. acquired a new stake in Ventas during the second quarter valued at approximately $30,000. Wiser Advisor Group LLC acquired a new stake in Ventas during the third quarter valued at approximately $27,000. Finally, IFC & Insurance Marketing Inc. bought a new stake in Ventas during the fourth quarter worth approximately $30,000. Institutional investors and hedge funds own 94.18% of the company's stock.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on the company. The Goldman Sachs Group reissued a "buy" rating and set a $110.00 price objective on shares of Ventas in a research note on Tuesday, May 19th. Scotiabank cut their target price on Ventas from $95.00 to $88.00 and set a "sector perform" rating on the stock in a research report on Thursday, June 18th. KeyCorp upped their target price on Ventas from $90.00 to $95.00 and gave the company an "overweight" rating in a report on Thursday, May 7th. Citigroup increased their price target on Ventas from $100.00 to $110.00 and gave the company a "buy" rating in a research report on Tuesday, August 4th. Finally, Wells Fargo & Company lifted their price target on Ventas from $93.00 to $96.00 and gave the stock an "overweight" rating in a research note on Monday, June 1st. Fourteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $98.00.

Ventas Stock Performance

Shares of VTR stock opened at $93.84 on Wednesday. The company has a debt-to-equity ratio of 0.86, a current ratio of 0.44 and a quick ratio of 0.44. Ventas, Inc. has a fifty-two week low of $66.38 and a fifty-two week high of $101.60. The stock's 50-day moving average is $91.76 and its two-hundred day moving average is $87.38. The firm has a market cap of $48.14 billion, a P/E ratio of 173.79, a PEG ratio of 2.16 and a beta of 0.69.

Ventas (NYSE:VTR - Get Free Report) last announced its quarterly earnings results on Wednesday, July 29th. The real estate investment trust reported $0.97 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.96 by $0.01. The business had revenue of $1.73 billion during the quarter, compared to analyst estimates of $1.68 billion. Ventas had a return on equity of 1.99% and a net margin of 4.08%.The firm's revenue was up 21.7% on a year-over-year basis. During the same period in the previous year, the company earned $0.87 EPS. Analysts predict that Ventas, Inc. will post 3.89 earnings per share for the current fiscal year.

Insider Transactions at Ventas

In other Ventas news, Director Michael J. Embler bought 2,500 shares of Ventas stock in a transaction on Wednesday, June 3rd. The stock was purchased at an average cost of $78.81 per share, for a total transaction of $197,025.00. Following the completion of the purchase, the director directly owned 19,202 shares of the company's stock, valued at $1,513,309.62. The trade was a 14.97% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 0.53% of the stock is owned by company insiders.

Ventas Company Profile

Ventas, Inc NYSE: VTR is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas' business model combines property ownership with active asset management and capital markets activity.

Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source